Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics - Takeaways - MDSpire

Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics

  • July 16, 2026

Share

  • 1

    The article titled 'Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients' has been retracted.

  • 2

    Concerns regarding the validity of the data were identified by the Frontiers Research Integrity Auditing team.

  • 3

    The authors did not provide raw data or satisfactory explanations during the investigation.

  • 4

    The Chief Editors of Frontiers in Medicine approved the retraction due to lack of confidence in the findings.

  • 5

    The authors have not responded to any correspondence regarding the retraction.

Original Source(s)

Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics

  • July 16, 2026

Related Content

Higher Steroid Exposure Linked to Systemic Adverse Events in CRSwNP

Higher annual oral corticosteroid exposure was associated with greater odds of systemic adverse events, with avascular bone necrosis and pneumonia showing dose-dependent associations with cumulative dose and osteoporosis associated with longer annual exposure duration.

Screening and validation of ZFYVE27 as a potential diagnostic biomarker for osteoporosis via integrative bioinformatics and machine learning approaches

Association between neutrophil percentage-to-albumin ratio and bone mineral density and prevalent osteoporosis in patients with type 2 diabetes mellitus